Creative Planning Regenxbio Inc. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Regenxbio Inc. stock. As of the latest transaction made, Creative Planning holds 14,620 shares of RGNX stock, worth $187,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,620
Previous 16,134
9.38%
Holding current value
$187,428
Previous $115,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RGNX
# of Institutions
182Shares Held
45.2MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$110 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$61.2 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$43.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$23.6 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $554M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...